These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10117768)

  • 1. P & T Committee response to evolving technologies: preparing for the launch of high-tech, high-cost products. Roundtable discussion.
    Seltzer JL; Wordell CJ; Nash D; Johnson NE; Gottlieb JE
    Hosp Formul; 1992 Apr; 27(4):379-80, 386-92. PubMed ID: 10117768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P & T Committee interview: strategies to ensure an effective formulary system.
    Riff L; Hutchinson R
    Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P & T Committee roundtable discussion: Eastern region Pt. II.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jul; 19(7):561-4, 568-70. PubMed ID: 10267389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience.
    Lewis RP; Moore TD
    Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies for septic shock: in or out of the barn door?
    Nash DB; Johnson NE; Gottlieb JE; Vlasses PH
    QRB Qual Rev Bull; 1991 Oct; 17(10):310-3. PubMed ID: 1745528
    [No Abstract]   [Full Text] [Related]  

  • 7. HA-1A monoclonal antibody (centoxin) guidelines. Ad hoc Austin City-Wide Formulary Committee for Review of HA-1A.
    Martin ES; Silverberg JM; Roberts MJ
    Hosp Pharm; 1991 Oct; 26(10):852-4. PubMed ID: 10114006
    [No Abstract]   [Full Text] [Related]  

  • 8. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P & T Committee roundtable discussion: Eastern region. Part I.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jun; 19(6):469-72, 475-6. PubMed ID: 10266565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of a clinical pharmacology consult service as a formulary management tool.
    Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E
    Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues in formulary management: therapeutic interchange. The value, cost, and quality of therapeutic interchange.
    Mahoney CD
    Hosp Formul; 1992 Oct; 27 Suppl 2():2-3. PubMed ID: 10122035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P & T Committee roundtable discussion: Great Lakes region. Part II.
    McQuone M; Salberg DJ; Weintraub M
    Hosp Formul; 1984 Feb; 19(2):129-32, 136-8, 147-8. PubMed ID: 10264742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How a longstanding P & T Committee identifies and meets current therapeutic challenges.
    Stross J; de Leon R; Volger B
    Hosp Formul; 1991 Sep; 26(9):717-22, 724. PubMed ID: 10114003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P & T Committee interview: Promoting rational drug use.
    Hunt TK; Herfindal ET
    Hosp Formul; 1988 Apr; 23(4):359-62, 365-6, 369. PubMed ID: 10286839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in formulary management: therapeutic interchange. Communicating a policy: roundtable discussion, Part 2.
    Cichon M; Mahoney C; Renshaw B; Cromer M; Rodriguez FA; DeGiulio H; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():9-12. PubMed ID: 10122037
    [No Abstract]   [Full Text] [Related]  

  • 17. Issues in formulary management: therapeutic interchange. Establishing guidelines: roundtable discussion, Part 1.
    Mahoney C; Cichon M; Cromer M; DeGiulio H; Renshaw B; Rodriguez FA; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():4-8. PubMed ID: 10122036
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost containment through P & T committee drug utilization review.
    Bender FH; DeMatteo CS
    Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing guidelines for biotechnology drug use: experience with antithrombin III.
    Romac DR; Poole P; Owings JT; Mahackian K; Foulke G; Tharratt RS; Albertson TE
    Formulary; 1995 Sep; 30(9):520-3, 525-7, 531. PubMed ID: 10151737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.